XML 45 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Stockholders’ Equity (Tables)
12 Months Ended
Dec. 31, 2025
Stockholders’ Equity [Abstract]  
Schedule of Restricted Stock Activity

A summary of restricted stock activity during the period January 1, 2024 to December 31, 2025 is as follows:

 

    Total
restricted
shares
    Weighted
average
fair market
value per
share
    Total
unvested
restricted
shares
    Weighted
average
fair market
value per
share
    Total
vested
restricted
shares
    Weighted
average
fair market
value per share
 
Outstanding January 1, 2024     783,167     $ 1.5000       -     $ -       783,167     $ 1.50  
Granted and issued     -       -       -       -       -       -  
Forfeited/Cancelled     -       -       -       -       -       -  
Vested     -       -       -       -       -       -  
Outstanding December 31, 2024     783,167     $ 1.5000       -     $ -       783,167     $ 1.50  
Granted and issued     67,500,000       0.0037       -       -       67,500,000       0.0037  
Forfeited/Cancelled     -       -       -       -       -       -  
Vested     -       -              -       -       -       -  
Outstanding December 31, 2025     68,283,167     $ 0.0207       -     $      -       68,283,167     $ 0.0207  
Schedule of Restricted Stock Granted, Issued and Exercisable

The restricted stock granted, issued and exercisable at December 31, 2025 is as follows:

 

    Restricted Stock Granted and Vested 
Grant date Price   Number Granted   Weighted Average
Fair Value per Share
 
$0.0037    67,500,000    0.0037 
$1.4700    683,167   $1.4700 
$1.5000    33,333    1.5000 
$1.6500    66,667    1.6500 
      68,283,167   $0.0207 
Schedule of Fair Value of the Warrants Granted and Issued

The fair value of the warrants granted and issued, as described above, were determined by using a Black Scholes valuation model using the following assumptions:

 

    Year ended
December 31,
2025
    Year ended
December 31,
2024
 
             
Conversion price   $ 0.0005 to 0.084     $ 0.084 to 0.345  
Risk free interest rate     3.77 to 4.46 %       3.73 to 4.56 %
Expected life of derivative liability     1 to 5 years         1 to 5 years  
Expected volatility of underlying stock     183.1 to 352.45 %       177.78 to 191.61
Expected dividend rate     0 %     0 %

The fair value of the options granted were determined by using a Black Scholes valuation model using the following assumptions:

 

    Year ended
December 31,
2025
    Year ended
December 31,
2024
 
             
Conversion price   $ 0.09     $      -  
Risk free interest rate     4.67 %     - %
Expected life of derivative liability     10 years       -  
Expected volatility of underlying stock     200.7 %     -
Expected dividend rate     0 %     - %
Schedule of Warrant Activity

A summary of warrant activity during the period January 1, 2024 to December 31, 2025 is as follows:
 

   Shares
Underlying
Warrants
   Exercise
price per
share
   Weighted average
exercise
price
 
Outstanding January 1, 2024   10,442,093   $0.345 to 5.625   $0.626500 
Granted   1,796,493    0.084 to 0.345    0.267000 
Increase in warrants issued due to anti-dilution price protection   9,773,028    0.0840    0.084000 
Forfeited   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2024   22,011,614   $0.084 – 5.625   $0.319900 
Granted   55,204,761    0.005 to 0.084    0.00474 
Increase in warrants issued due to anti-dilution price protection   2,157,367,790    0.0005    0.00050 
Cancellation of warrants exchanged for common stock   (1,853,425,066)   0.0005 to $4.50    0.00149 
Forfeited   (531,165)   0.0005 to 1.035    0.97430 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2025   380,627,934   $0.0005 – 5.625   $0.01052 
Schedule of Warrants Outstanding and Exercisable

The warrants outstanding and exercisable at December 31, 2025 are as follows:

 

    Warrants Outstanding   Warrants Exercisable 
Exercise Price*   Number
Outstanding
   Weighted
Average
Remaining
Contractual
life in years
   Weighted
Average
Exercise
Price
   Number
Exercisable
   Weighted
Average
Exercise Price
   Weighted
Average
Remaining
Contractual
life in years
 
$0.000500    370,585,100    3.25         370,585,100         3.25 
$0.010000    2,550,000    4.76         2,550,000         4.76 
$0.345000    6,939,718    2.69         6,939,718         2.69 
$0.450000    266,668    2.48         266,668         2.48 
$1.500000    33,334    2.61         33,334         2.61 
$4.500000    172,225    0.21         172,225         0.21 
$5.625000    80,889    0.21         80,889         0.21 
      380,627,934    3.25   $0.01052    380,627,934   $0.01052    3.25 
Schedule of Option Activity

A summary of option activity during the period January 1, 2024 to December 31, 2025 is as follows:

 

   Shares
Underlying
options
   Exercise
price per
share
   Weighted average
exercise
price
 
Outstanding January 1, 2024   1,520,002    $1.20 to 4.50   $4.46 
Granted   
-
    
-
    
-
 
Forfeited/Cancelled   (6,667)   1.20    1.20 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2024   1,513,335    $1.20 to 4.50   $4.47 
Granted   600,000    0.09    0.09 
Forfeited/Cancelled   (333,334)   4.50    4.50 
Exercised   
-
    
-
    
-
 
Outstanding December 31, 2025   1,780,001    $0.09 to 4.50   $2.989 
Schedule of Options Outstanding and Exercisable

The options outstanding and exercisable at December 31 2025 are as follows:

 

    Options Outstanding   Options Exercisable 
Exercise Price*   Number Outstanding   Weighted
Average Remaining Contractual
life in years
   Weighted Average
Exercise Price
   Number Exercisable   Weighted Average
Exercise Price
   Weighted Average Remaining Contractual life in years 
$0.09    600,000    9.02         400,000         9.02 
$1.20    13,334    6.71         13,334         6.71 
$4.50    1,166,667    6.01         1,166,667         6.01 
      1,780,001    7.03   $2.989    1,580,001   $3.36    6.78